These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30514783)

  • 21. Coregulation of extracellular vesicle production and fluconazole susceptibility in
    Rizzo J; Trottier A; Moyrand F; Coppée JY; Maufrais C; Zimbres ACG; Dang TTV; Alanio A; Desnos-Ollivier M; Mouyna I; Péhau-Arnaude G; Commere PH; Novault S; Ene IV; Nimrichter L; Rodrigues ML; Janbon G
    mBio; 2023 Aug; 14(4):e0087023. PubMed ID: 37310732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A.
    Florio AR; Ferrari S; De Carolis E; Torelli R; Fadda G; Sanguinetti M; Sanglard D; Posteraro B
    BMC Microbiol; 2011 May; 11():97. PubMed ID: 21569340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
    Li LP; Liu W; Liu H; Zhu F; Zhang DZ; Shen H; Xu Z; Qi YP; Zhang SQ; Chen SM; He LJ; Cao XJ; Huang X; Zhang JD; Yan L; An MM; Jiang YY
    PLoS One; 2015; 10(5):e0126393. PubMed ID: 25992630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans.
    Dbouk NH; Covington MB; Nguyen K; Chandrasekaran S
    BMC Microbiol; 2019 Nov; 19(1):243. PubMed ID: 31694529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term exposure to fluconazole induces chromosome loss in Candida albicans: an approach to produce haploid cells.
    Chang FM; Ou TY; Cheng WN; Chou ML; Lee KC; Chin YP; Lin CP; Chang KD; Lin CT; Su CH
    Fungal Genet Biol; 2014 Sep; 70():68-76. PubMed ID: 25038494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B.
    Carlson T; Lupinacci E; Moseley K; Chandrasekaran S
    FEMS Microbiol Lett; 2021 May; 368(7):. PubMed ID: 33877319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of cryptococcal meningitis and fluconazole heteroresistance in
    Huang Y; Zhang Y; Yang S; Lu H; Yu H; Wang X; Jia X; Tang D; Wu L; Huang S; Yang P
    Microbiol Spectr; 2024 Aug; 12(8):e0072524. PubMed ID: 39007718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluconazole assists berberine to kill fluconazole-resistant Candida albicans.
    Li DD; Xu Y; Zhang DZ; Quan H; Mylonakis E; Hu DD; Li MB; Zhao LX; Zhu LH; Wang Y; Jiang YY
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6016-27. PubMed ID: 24060867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heteroresistance of Cryptococcus gattii to fluconazole.
    Varma A; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2303-11. PubMed ID: 20385871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antiproliferative peptide Ctn[15-34] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans.
    de Aguiar FLL; Cavalcante CSDP; Dos Santos Fontenelle RO; Falcão CB; Andreu D; Rádis-Baptista G
    J Appl Microbiol; 2020 Feb; 128(2):414-425. PubMed ID: 31626724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence.
    Ben-Ami R; Zimmerman O; Finn T; Amit S; Novikov A; Wertheimer N; Lurie-Weinberger M; Berman J
    mBio; 2016 Aug; 7(4):. PubMed ID: 27486188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans.
    Bastos RW; Carneiro HCS; Oliveira LVN; Rocha KM; Freitas GJC; Costa MC; Magalhães TFF; Carvalho VSD; Rocha CE; Ferreira GF; Paixão TA; Moyrand F; Janbon G; Santos DA
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109169
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
    Sionov E; Chang YC; Garraffo HM; Dolan MA; Ghannoum MA; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1162-9. PubMed ID: 22155829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5.
    Zhou J; Li J; Cheong I; Liu NN; Wang H
    Bioorg Med Chem; 2021 Aug; 44():116293. PubMed ID: 34243044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unisexual and heterosexual meiotic reproduction generate aneuploidy and phenotypic diversity de novo in the yeast Cryptococcus neoformans.
    Ni M; Feretzaki M; Li W; Floyd-Averette A; Mieczkowski P; Dietrich FS; Heitman J
    PLoS Biol; 2013 Sep; 11(9):e1001653. PubMed ID: 24058295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aneuploidy Mediates Rapid Adaptation to a Subinhibitory Amount of Fluconazole in Candida albicans.
    Sun LL; Li H; Yan TH; Fang T; Wu H; Cao YB; Lu H; Jiang YY; Yang F
    Microbiol Spectr; 2023 Feb; 11(2):e0301622. PubMed ID: 36853047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant
    Xu Y; Quan H; Wang Y; Zhong H; Sun J; Xu J; Jia N; Jiang Y
    Front Cell Infect Microbiol; 2017; 7():491. PubMed ID: 29238700
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
    Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
    Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.